Supreme Court retains nationwide access to mifepristone | Image Credit: © SeanPavonePhoto - © SeanPavonePhoto - stock.adobe.com. The Supreme Court has rejected a challenge from antiabortion doctors to limit access to mifepristone for medication abortion, allow patients to continue accessing the pill nationwide.1Takeaways The Supreme Court unanimously rejected a challenge from antiabortion doctors to limit access to mifepristone, maintaining nationwide access to the medication. The unanimous ruling reversed a lower court decision to restrict access to mifepristone, which is used in over 60% of abortions in the United States. When accepting the case, the Supreme Court stated it would evaluate the rule changes in 2016 and 2021 that increased access to mifepristone and would not consider taking mifepristone off the market. The Supreme Court concluded that none of the plaintiffs’ theories were strong enough to establish a standing.

Source: Washington Post June 13, 2024 15:43 UTC